Study

The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. – Cost Effective Supplements

The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/12230594


Conclusion of this study

MIG-99 was shown to be effective only in a small predefined subgroup of patients with at least four attacks during the 28-day baseline period where the most favourable benefit-risk ratio was observed with a dosage of three capsules of 6.25 mg MIG-99 extract per day.


Supplements analyzed in this study

Feverfew

Health conditions analyzed in this study

Migraine


Highly Positive
Feverfew



Highly Positive
Feverfew


Functions related to this study

Mental health


Highly Positive
Feverfew


Body systems related to this study


Nervous System
Scroll to top